US Broker Ratings

Chemed Corp (CHE) Investor Outlook: Analysts Eye 35.50% Upside Potential

Chemed Corp (NYSE: CHE), a key player in the healthcare sector with a focus on medical care facilities, presents an intriguing proposition for investors seeking both stability and growth potential...

Qiagen N.V. (QGEN) Stock Analysis: Navigating a 11.91% Potential Upside in Healthcare Diagnostics

Qiagen N.V. (NYSE: QGEN) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Based in Venlo, the Netherlands, this $9.8 billion company is renowned..

Teva Pharmaceutical Industries (TEVA) Stock Report: Analyst Consensus Points to 8.24% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA) stands as a formidable player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a robust market capitalization of..

UnitedHealth Group (UNH) Stock Analysis: Understanding the 16.6% Potential Upside for Investors

Investors looking for stability and growth in the healthcare sector need look no further than UnitedHealth Group Incorporated (NYSE: UNH). As a heavyweight in the healthcare plans industry, UnitedHealth operates..

GSK plc (GSK) Stock Analysis: Evaluating the Healthcare Giant’s Potential with a Robust 41.52% ROE

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, continues to attract the attention of investors with its diverse portfolio and a strong presence in the global pharmaceutical landscape...

Agilent Technologies (A): Analyzing Growth Potential with a 22% Upside in the Diagnostics Arena

Agilent Technologies, Inc. (NYSE: A), a venerable name in the healthcare sector, particularly within the diagnostics and research industry, is capturing investor attention with its strong market presence and promising..

Medpace Holdings, Inc. (MEDP) Investor Outlook: Navigating a 23.70% Revenue Growth in the Healthcare Sector

Investors eyeing the healthcare sector have likely noticed Medpace Holdings, Inc. (NASDAQ: MEDP), a prominent player in the diagnostics and research industry. Based in Cincinnati, Ohio, Medpace offers a comprehensive..

Doximity, Inc. (DOCS) Stock Analysis: Exploring a 56.85% Potential Upside in the Healthcare Sector

Doximity, Inc. (NASDAQ: DOCS) is capturing investor attention with its robust digital platform tailored for healthcare professionals. As of its latest market snapshot, Doximity boasts a market capitalization of $8.15..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Powerhouse with 22% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology sector, drawing attention from investors with its remarkable growth potential and strong analyst support. Based in Hellerup, Denmark, this..

AbbVie Inc. (ABBV) Stock Analysis: Unpacking Growth with a Robust 6.70% Potential Upside

AbbVie Inc. (NYSE: ABBV), a titan in the biopharmaceutical sector, continues to captivate investor interest with its impressive market presence and potential for future growth. With a market capitalization of..

Smith & Nephew SNATS, Inc. (SNN) Investor Outlook: Exploring a Promising 11.41% Upside Potential

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, continues to draw attention from investors with its robust market presence and significant upside potential. As a..

ICON plc (ICLR) Investor Outlook: Analyzing Upside Potential and Market Position

ICON plc (NASDAQ: ICLR) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Dublin, Ireland, ICON specializes in providing outsourced development..

West Pharmaceutical Services, Inc. (WST): Investor Outlook Reveals 25% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST) stands out as a compelling opportunity in the healthcare sector, particularly within the niche of medical instruments and supplies. With a robust market capitalization..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 31.74% Potential Upside in the Healthcare Sector

Investors in AptarGroup, Inc. (NYSE: ATR) are eyeing a significant potential upside, with analysts suggesting a 31.74% increase from the current price of $122.54 to an average target of $161.43...

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 33% Potential Upside for Investors

For investors seeking opportunities in the healthcare sector, HealthEquity, Inc. (NASDAQ: HQY) presents an intriguing proposition. With a market capitalization of $7.88 billion, HealthEquity stands at the intersection of health..

Elevance Health, Inc. (ELV) Stock Report: Analyzing Growth Potential with a 9.87% Upside

Investors eyeing the healthcare sector should take a closer look at Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans industry. With a substantial market capitalization of..

Haleon plc (HLN) Stock Analysis: A 17.23% Potential Upside Catches Investor Attention

Haleon plc (HLN), a prominent player in the healthcare sector, has carved a niche as a leading manufacturer of specialty and generic drugs. With a substantial market capitalization of $44.53..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Evaluating an 87.25% Potential Upside in the Biotech Arena

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, has captured investor attention with its promising pipeline and significant potential upside. With a market capitalization of $13.04..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Evaluating Growth Potential and Analyst Sentiment

Intuitive Surgical, Inc. (NASDAQ: ISRG) is a formidable presence in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $201.46 billion, this U.S.-based..

BioNTech SE (BNTX) Stock Analysis: Navigating a 42.75% Potential Upside in the Biotechnology Sector

Investors with a keen interest in the biotechnology sector may find BioNTech SE (NASDAQ: BNTX) an intriguing opportunity. This German healthcare giant, known for its groundbreaking work in immunotherapies for..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds